2019年冠状病毒病(COVID-19)
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
微阵列
逆转录聚合酶链式反应
冠状病毒
病毒学
2019-20冠状病毒爆发
实时聚合酶链反应
荧光
抗原
蛋白质微阵列
大流行
分子生物学
化学
医学
生物
基因
信使核糖核酸
免疫学
病理
物理
基因表达
生物化学
光学
疾病
传染病(医学专业)
爆发
作者
Zewei Lian,Tingqing Wu,Huadong Wang,Jimei Chi,Lijun Cheng,Daixi Xie,Xiangyu Pan,Yuming Hu,Zhiyu Tan,Sisi Chen,Yang Xu,Yun Yang,Wei Wu,Chunbao Li,Meng Su,Yanlin Song
出处
期刊:Small
[Wiley]
日期:2023-03-29
卷期号:19 (28)
被引量:6
标识
DOI:10.1002/smll.202301162
摘要
Abstract Rapid and ultra‐sensitive detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is critical for early screening and management of COVID‐19. Currently, the real‐time reverse transcription polymerase chain reaction (rRT‐PCR) is the primary laboratory method for diagnosing SARS‐CoV‐2. It is not suitable for at‐home COVID‐19 diagnostic test due to the long operating time, specific equipment, and professional procedures. Here an all‐printed photonic crystal (PC) microarray with portable device for at‐home COVID‐19 rapid antigen test is reported. The fluorescence‐enhanced effect of PC amplifies the fluorescence intensity of the labeled probe, achieving detection of nucleocapsid (N‐) protein down to 0.03 pg mL −1 . A portable fluorescence intensity measurement instrument gives the result (negative or positive) by the color of the indicator within 5 s after inserting the reacted PC microarray test card. The N protein in inactivated virus samples (with cycle threshold values of 26.6–40.0) can be detected. The PC microarray provides a general and easy‐to‐use method for the timely monitoring and eventual control of the global coronavirus pandemic.
科研通智能强力驱动
Strongly Powered by AbleSci AI